GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view
22 10월 2024 - 1:10AM
Business Wire
- Application goes beyond data aggregation to help clinicians
quickly see a longitudinal view of their patient’s history,
spotlighting disease progression and helping to inform proactive
interventions
- Tampa General Hospital and UT Southwestern Medical Center to be
early evaluators of CareIntellect for Oncology
- Application is the first within GE HealthCare’s new
CareIntellect offering of clinical and operational applications,
built to reduce provider integration burden and increase adoption
speed for new applications
GE HealthCare (Nasdaq: GEHC) today announced CareIntellect for
Oncology, a new cloud-first application that brings together
multi-modal patient data from disparate systems into a single view,
using generative AI to summarize clinical notes and reports. The
application also surfaces relevant data allowing care teams to
quickly understand disease progression and flag potential
deviations from the treatment plan to help the clinician determine
potential next steps and inform proactive interventions. The
application, which is planned to be available to customers in U.S.
next year, will initially focus on prostate and breast cancer. It
organizes structured and unstructured data (e.g., medical images,
medical records, notes, and device readings), summarizes complex
medical histories, supports treatment response assessments, helps
assess clinical trial eligibility, and tracks adherence to
treatment protocols in an easy-to-navigate view. This is the first
application within GE HealthCare’s new CareIntellect offering of
clinical and operational applications designed to help healthcare
providers quickly and easily install new applications without
having to take a costly and time-consuming product-by-product
integration approach.
Today physicians spend a significant amount of time getting up
to speed on a patient’s history and care status—for a new patient
this can take hours. The process is time-consuming and frustrating
for clinicians because they need to assess a large volume of
unstructured and multi-modal information stored across various
siloed systems in order to find the necessary information and
determine the best course of treatment. It also puts a significant
cognitive burden on the clinician to identify any deviation in
adherence to the treatment plan that could signal an emerging
issue. For many cancer patients, the treatment journey lasts years
and involves numerous doctor visits, tests, and treatments across
several care settings. The result is a complex care journey that is
difficult and time-consuming for care teams to review and assess
and can negatively impact the patient experience and standard of
care. Matching patients to potentially suitable clinical trials is
also painstaking work, with 80% of oncologists reporting that they
feel overwhelmed by the amount of new research and clinical trial
information that they need to keep up with.[ii]
CareIntellect for Oncology quickly organizes multi-modal patient
data from disparate systems to provide care teams with a concise
view of the patient’s progressive treatment journey, while allowing
clinicians to maintain full access to the source reports. The
application will allow care teams to reduce or eliminate the
time-consuming task of searching multiple databases—reducing a
process that can take several hours, down to several minutes by
eliminating the need to track down and synthesize information
across multiple reports. The application is also able to flag risk
of deviation from the treatment plan, helping the clinician
determine potential next steps to intervene—for example, surfacing
a patient’s missed lab work that could delay the next round of
treatment. Additionally, CareIntellect for Oncology helps care
teams assess potentially suitable clinical trials by comparing the
patient’s health record to trial criteria.
Tampa General Hospital and UT Southwestern Medical Center will
be early evaluators of CareIntellect for Oncology, and integration
is already underway. The application is planned to be available
widely to U.S. customers in 2025, with additional future expansion
intended for Canada, the UK, and Ireland.
“Currently only 3% of hospital data is used because of the
complexities associated with organizing and extracting useful
healthcare insights at scale.[iii] Yet there is so much potential
to turn the other 97% into actionable data to advance healthcare,
but it is critical that any new technologies we develop be
efficient and easy to use while reducing cognitive burdens for
clinicians and removing implementation hurdles for providers,” said
Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at
GE HealthCare. “CareIntellect is designed to help providers
streamline access to critical patient information and surface key
changes since the patient’s last visit. By ensuring the provider
has the right information at their fingertips, they can spend less
time sifting through information and more time helping
patients.”
“Tampa General Hospital is looking forward to evaluating
CareIntellect for Oncology to provide our care teams with
information to move from analysis to action—including making use of
the proactive pathways to inform care progression and clinical
trial eligibility information,” said Dr. Peter Chang, Senior Vice
President, Chief Transformation Officer at Tampa General Hospital.
“We were impressed by how quickly GE HealthCare was able to design
the application to include breast cancer in a matter of weeks. We
look forward to putting this in the hands of our care teams and
using the AI-enabled functionality to help clinicians spend time
where it matters most—delivering outstanding patient care.”
CareIntellect for Oncology is the first application available as
part of GE HealthCare’s new CareIntellect family of clinical and
operational applications. CareIntellect applications will use a
common, cloud-first digital infrastructure that enables healthcare
providers to quickly and easily onboard new applications and
capabilities to help solve both clinical and operational needs.
CareIntellect aims to help customers go through the integration
process once, while allowing them to activate additional
applications easily and securely to minimize costly and
time-consuming additional product-by-product integration. It will
also be compatible with providers’ existing single sign-on systems
to avoid the hassle of multiple log-ins. This means hospitals could
accelerate their digital transformation by spending less time with
their IT setup and more time unlocking their data to drive
operational efficiency improvements and more personalized care.
To learn more about these solutions and see a demo, visit GE
HealthCare in the AI Pavilion at booth #3816 at HLTH 2024 in Las
Vegas, NV from October 20-23 or visit
https://www.gehealthcare.com.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 125 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Ultrasound, Patient Care Solutions,
and Pharmaceutical Diagnostics businesses help improve patient care
from diagnosis, to therapy, to monitoring. We are a $19.6 billion
business with approximately 51,000 colleagues working to create a
world where healthcare has no limits.
Follow us on LinkedIn, X , Facebook, Instagram, and Insights for
the latest news, or visit our website https://www.gehealthcare.com/
for more information.
[i] J. Marc Overhage and David McCallie Jr, “Physician Time
Spent Using the Electronic Health Record During Outpatient
Encounters: A Descriptive Study,” Ann Intern Med., October 6, 2020,
https://pubmed.ncbi.nlm.nih.gov/31931523/. [ii] “Physician Learning
Preferences,” Doximity, October 2022,
https://c8y.doxcdn.com/image/upload/Press%20Blog/Research%20Reports/Doximity-Physician-Learning-Report-2022.pdf
[iii] Deloitte, “A holistic approach to unlock the value of health
data,” March 2023,
https://www2.deloitte.com/content/dam/Deloitte/be/Documents/life-sciences-health-care/Health%20Data.pdf
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241021006095/en/
GE HealthCare Media Contact: Sofia Mata-Leclerc Head of
Communications, Science and Technology
Sofia.Mata-Leclerc@gehealthcare.com
GE HealthCare Technologies (NASDAQ:GEHC)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
GE HealthCare Technologies (NASDAQ:GEHC)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024